Advocate Medical Group 1460 N Halsted St STE 401, Chicago, IL 60642 7738800320 (phone), 3122045501 (fax)
Chicago Foot Health Center 3000 N Halsted St STE 821, Chicago, IL 60657 7732967160 (phone), 7732963440 (fax)
Chicago Foot Health Centers 17019 Harlem Ave, Tinley Park, IL 60477 7085323233 (phone), 7732963440 (fax)
Procedures:
Arthrocentesis
Conditions:
Plantar Fascitis Tinea Pedis Hallux Valgus
Languages:
English Polish Spanish
Description:
Dr. Pietz works in Chicago, IL and 2 other locations and specializes in Podiatric Medicine. Dr. Pietz is affiliated with Advocate Illinois Masonic Medical Center.
Kathleen Barton - Lake Forest IL, US Thomas Borchardt - Pleasant Prairie WI, US Marlon Carlos - Des Plaines IL, US Subhash Desai - Wilmette IL, US Leonard Ferro - Highland Park IL, US Henry Gaud - Evanston IL, US Scott Ganser - Park City IL, US Clay Little - Lindenhurst IL, US Partha Mudipalli - Skokie IL, US Mark Pietz - Grayslake IL, US Daniel Pilipauskas - Glenview IL, US Yuen-Lung Sing - St. Louis MO, US Glenn Stahl - Buffalo Grove IL, US Joseph Wieczorek - Cary IL, US Chris Yan - Plainsboro IL, US
International Classification:
C07J001/00 C07J021/00
US Classification:
540/002000, 540/041000
Abstract:
A novel crystalline form (Form L) of the aldosterone receptor antagonist drug eplerenone is provided having relatively high physical stability at normal temperatures of storage and use. Pharmaceutical compositions are also provided comprising Form L eplerenone, optionally accompanied by one or more other solid state forms of eplerenone, in a total unit dosage amount of eplerenone of about 10 to about 1000 mg, and further comprising one or more pharmaceutically acceptable excipients. Processes are provided for preparing Form L eplerenone and for preparing compositions comprising Form L eplerenone. A method for prophylaxis and/or treatment of an aldosterone-mediated condition or disorder is also provided, comprising administering to a subject a therapeutically effective amount of eplerenone, wherein at least a fraction of the eplerenone present is Form L eplerenone.
Eplerenone Drug Substance Having High Phase Purity
Kathleen Barton - Lake Forest IL, US Thomas Borchardt - Pleasant Prairie WI, US Marlon Carlos - Des Plaines IL, US Subhash Desai - Wilmette IL, US Leonard Ferro - Highland Park IL, US Henry Gaud - Evanston IL, US Scott Ganser - Park City IL, US Clay Little - Lindenhurst IL, US Partha Mudipalli - Skokie IL, US Mark Pietz - Grayslake IL, US Daniel Pilipauskas - Glenview IL, US Yuen-Lung Sing - St. Louis MO, US Glenn Stahl - Buffalo Grove IL, US Joseph Wieczorek - Cary IL, US Chris Yan - Vernon Hills IL, US
International Classification:
C07J053/00
US Classification:
540/047000
Abstract:
A novel crystalline form (Form L) of the aldosterone receptor antagonist drug eplerenone is provided having relatively high physical stability at normal temperatures of storage and use. Pharmaceutical compositions are also provided comprising Form L eplerenone, optionally accompanied by one or more other solid state forms of eplerenone, in a total unit dosage amount of eplerenone of about 10 to about 1000 mg, and further comprising one or more pharmaceutically acceptable excipients. Processes are provided for preparing Form L eplerenone and for preparing compositions comprising Form L eplerenone. A method for prophylaxis and/or treatment of an aldosterone-mediated condition or disorder is also provided, comprising administering to a subject a therapeutically effective amount of eplerenone, wherein at least a fraction of the eplerenone present is Form L eplerenone.
Eplerenone Crystal Form Exhibiting Enhanced Dissolution Rate
Kathleen Barton - Lake Forest IL, US Thomas Borchardt - Pleasant Prairie WI, US Marlon Carlos - Des Plaines IL, US Subhash Desai - Wilmette IL, US Leonard Ferro - Highland Park IL, US Henry Gaud - Evanston IL, US Scott Ganser - Park City IL, US Clay Little - Lindenhurst IL, US Partha Mudipalli - Skokie IL, US Mark Pietz - Grayslake IL, US Daniel Pilipauskas - Glenview IL, US Yuen-Lung Sing - St. Louis MO, US Glenn L. Stahl - Buffalo Grove IL, US Joseph Wieczorek - Cary IL, US Chris Yan - Plainsboro NJ, US
Assignee:
Pharmacia Corporation - Peapack NJ
International Classification:
A61K031/585 C07J071/00
US Classification:
540016000, 514173000
Abstract:
A novel crystalline form (Form H) of the aldosterone receptor antagonist drug eplerenone is provided having a relatively rapid dissolution rate in aqueous media. Also provided are novel solvated crystalline forms of eplerenone that, when desolvated, can yield Form H eplerenone. Also provided is amorphous eplerenone. Pharmaceutical compositions are provided comprising Form H eplerenone, optionally accompanied by one or more other solid state forms of eplerenone, in a total unit dosage amount of eplerenone of about 10 to about 1000 mg, and further comprising one or more pharmaceutically acceptable excipients. Processes are provided for preparing Form H eplerenone and for preparing compositions comprising Form H eplerenone. A method for prophylaxis and/or treatment of an aldosterone-mediated condition or disorder is also provided, comprising administering to a subject a therapeutically effective amount of eplerenone, wherein at least a fraction of the eplerenone present is Form H eplerenone.
Eplerenone Drug Substance Having High Phase Purity
Kathleen Barton - Lake Forest IL, US Thomas Borchardt - Pleasant Prairie WI, US Marlon Carlos - Des Plaines IL, US Subhash Desai - Wilmette IL, US Leonard Ferro - Highland Park IL, US Henry Gaud - Evanston IL, US Scott Ganser - Park City IL, US Clay Little - Lindenhurst IL, US Partha Mudipalli - Skokie IL, US Mark Pietz - Grayslake IL, US Daniel Pilipauskas - Glenview IL, US Yuen-Lung Sing - St. Louis MO, US Glenn Stahl - Buffalo Grove IL, US Joseph Wieczorek - Cary IL, US Chris Yan - Plainsboro NJ, US
Assignee:
Pharmacia Corporation - Peapack NJ
International Classification:
C07J071/00 A61K031/58
US Classification:
514173000, 540025000
Abstract:
A novel crystalline form (Form L) of the aldosterone receptor antagonist drug eplerenone is provided having relatively high physical stability at normal temperatures of storage and use. Pharmaceutical compositions are also provided comprising Form L eplerenone, optionally accompanied by one or more other solid state forms of eplerenone, in a total unit dosage amount of eplerenone of about 10 to about 1000 mg, and further comprising one or more pharmaceutically acceptable excipients. Processes are provided for preparing Form L eplerenone and for preparing compositions comprising Form L eplerenone. A method for prophylaxis and/or treatment of an aldosterone-mediated condition or disorder is also provided, comprising administering to a subject a therapeutically effective amount of eplerenone, wherein at least a fraction of the eplerenone present is Form L eplerenone.
Eplerenone Crystalline Form Exhibiting Enhanced Dissolution Rate
Kathleen Barton - Lake Forest IL, US Thomas Borchardt - Pleasant Prairie WI, US Marlon Carlos - Des Plaines IL, US Subhash Desai - Wilmette IL, US Leonard Ferro - Highland Park IL, US Henry Gaud - Evanston IL, US Scott Ganser - Park City IL, US Clay Little - Lindenhurst IL, US Partha Mudipalli - Skokie IL, US Mark Pietz - Grayslake IL, US Daniel Pilipauskas - Glenview IL, US Yuen-Lung Sing - St. Louis MO, US Glenn Stahl - Buffalo Grove IL, US Joseph Wieczorek - Cary IL, US Chris Yan - Plainsboro NJ, US
Assignee:
G.D. Searle & Co. - Chicago IL
International Classification:
C07J021/00
US Classification:
540041000
Abstract:
A novel crystalline form (Form H) of the aldosterone receptor antagonist drug eplerenone is provided having a relatively rapid dissolution rate in aqueous media. Also provided are novel solvated crystalline forms of eplerenone that, when desolvated, can yield Form H eplerenone. Also provided is amorphous eplerenone. Pharmaceutical compositions are provided comprising Form H eplerenone, optionally accompanied by one or more other solid state forms of eplerenone, in a total unit dosage amount of eplerenone of about 10 to about 1000 mg, and further comprising one or more pharmaceutically acceptable excipients. Processes are provided for preparing Form H eplerenone and for preparing compositions comprising Form H eplerenone. A method for prophylaxis and/or treatment of an aldosterone-mediated condition or disorder is also provided, comprising administering to a subject a therapeutically effective amount of eplerenone, wherein at least a fraction of the eplerenone present is Form H eplerenone.
Eplerenone Drug Substance Having High Phase Purity
Kathleen P. Barton - Lake Forest IL, US Thomas B. Borchardt - Pleasant Prairie WI, US Marlow V. Carlos - Des Plaines IL, US Subhash Desai - Wilmette IL, US Leonard J. Ferro - Highland Park IL, US Henry T. Gaud - Evanston IL, US Scott S. Ganser - Park City IL, US Clay R. Little - Lindenhurst IL, US Partha S. Mudipalli - Skokie IL, US Mark A. Pietz - Grayslake IL, US Daniel R. Pilipauskas - Glenview IL, US Yuen-Lung L. Sing - St. Louis MO, US Glenn L. Stahl - Buffalo Grove IL, US Joseph J. Wieczorek - Cary IL, US Chris Y. Yan - Plainsbore NJ, US
International Classification:
C07J 71/00 A61K 31/58 A61P 5/00
US Classification:
514173, 540 23
Abstract:
A novel crystalline form (Form L) of the aldosterone receptor antagonist drug eplerenone is provided having relatively high physical stability at normal temperatures of storage and use. Pharmaceutical compositions are also provided comprising Form L eplerenone, optionally accompanied by one or more other solid state forms of eplerenone, in a total unit dosage amount of eplerenone of about 10 to about 1000 mg, and further comprising one or more pharmaceutically acceptable excipients. Processes are provided for preparing Form L eplerenone and for preparing compositions comprising Form L eplerenone. A method for prophylaxis and/or treatment of an aldosterone-mediated condition or disorder is also provided, comprising administering to a subject a therapeutically effective amount of eplerenone, wherein at least a fraction of the eplerenone present is Form L eplerenone.
Eplerenone Crystalline Form Exhibiting Enhanced Dissolution Rate
Kathleen Barton - Lake Forest IL, US Thomas Borchardt - Pleasant Prairie WI, US Marlon Carlos - Des Plaines IL, US Subhash Desai - Wilmette IL, US Leonard Ferro - Highland Park IL, US Henry Gaud - Evanston IL, US Scott Ganser - Park City IL, US Clay Little - Lindenhurst IL, US Partha Mudipalli - Skokie IL, US Mark Pietz - Grayslake IL, US Daniel Pilipauskas - Glenview IL, US Yuen-Lung Sing - St. Louis MO, US Glenn Stahl - Buffalo Grove IL, US Joseph Wieczorek - Cary IL, US Chris Yan - Plainsboro NJ, US
International Classification:
C07J017/00 C07J001/00 C07J021/00
US Classification:
540/002000, 540/116000, 540/041000
Abstract:
A novel crystalline form (Form H) of the aldosterone receptor antagonist drug eplerenone is provided having a relatively rapid dissolution rate in aqueous media. Also provided are novel solvated crystalline forms of eplerenone that, when desolvated, can yield Form H eplerenone. Also provided is amorphous eplerenone. Pharmaceutical compositions are provided comprising Form H eplerenone, optionally accompanied by one or more other solid state forms of eplerenone, in a total unit dosage amount of eplerenone of about 10 to about 1000 mg, and further comprising one or more pharmaceutically acceptable excipients. Processes are provided for preparing Form H eplerenone and for preparing compositions comprising Form H eplerenone. A method for prophylaxis and/or treatment of an aldosterone-mediated condition or disorder is also provided, comprising administering to a subject a therapeutically effective amount of eplerenone, wherein at least a fraction of the eplerenone present is Form H eplerenone.
License Records
Mark G Pietz
Address:
Tinley Park, IL 60477
License #:
1797 - Expired
Issued Date:
Jul 10, 1985
Expiration Date:
Dec 31, 2016
Type:
Podiatrist
Name / Title
Company / Classification
Phones & Addresses
17019 Harlem Ave, Tinley Park, IL 60477
Mark Pietz ManagingPodiatrist, Manager
Chicago Foot Health Center LLC Podiatrist's Office · Offices and Clinics of Podiatrists · Offices of Podiatrists · Podiatrists
17051 Harlem Ave, Tinley Park, IL 60477 17019 Harlem Ave, Tinley Park, IL 60477 7085323233, 7085326568
Mark G. Pietz Podiatrist
Harbor Medical Group Physician's Office · Family Doctor · Internist · Offices of Physicians, Except Mental Health
1460 N Halsted St, Chicago, IL 60642 111 N Wabash Ave, Chicago, IL 60602 111 N Wabash Ave 1710, Chicago, IL 60602 3126412921, 3127912040